GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » Cyclically Adjusted FCF per Share

Celltrion (XKRX:068270) Cyclically Adjusted FCF per Share : ₩1,122.88 (As of Mar. 2025)


View and export this data going back to 2005. Start your Free Trial

What is Celltrion Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Celltrion's adjusted free cash flow per share for the three months ended in Mar. 2025 was ₩246.955. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩1,122.88 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Celltrion's average Cyclically Adjusted FCF Growth Rate was 41.10% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 14.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 39.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Celltrion was 89.30% per year. The lowest was 14.10% per year. And the median was 50.20% per year.

As of today (2025-05-31), Celltrion's current stock price is ₩161000.00. Celltrion's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ₩1,122.88. Celltrion's Cyclically Adjusted Price-to-FCF of today is 143.38.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Celltrion was 9289.71. The lowest was 135.99. And the median was 400.10.


Celltrion Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Celltrion's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celltrion Cyclically Adjusted FCF per Share Chart

Celltrion Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 188.24 712.54 644.88 762.93 1,057.52

Celltrion Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 795.78 901.53 922.31 1,057.52 1,122.88

Competitive Comparison of Celltrion's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Celltrion's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celltrion's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celltrion's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Celltrion's Cyclically Adjusted Price-to-FCF falls into.


;
;

Celltrion Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Celltrion's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=246.955/122.5900*122.5900
=246.955

Current CPI (Mar. 2025) = 122.5900.

Celltrion Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -252.300 100.051 -309.138
201509 -228.226 100.111 -279.473
201512 24.341 100.220 29.774
201603 51.155 100.561 62.361
201606 -453.547 100.791 -551.641
201609 285.045 101.461 344.404
201612 704.727 101.561 850.644
201703 1,005.604 102.851 1,198.603
201706 376.414 102.611 449.703
201709 227.657 103.491 269.672
201712 965.077 102.991 1,148.732
201803 493.680 104.101 581.362
201806 247.462 104.130 291.331
201809 48.640 105.651 56.439
201812 373.553 104.351 438.846
201903 545.588 104.491 640.091
201906 109.514 104.881 128.005
201909 320.698 105.200 373.710
201912 244.087 105.121 284.649
202003 -26.337 105.354 -30.646
202006 313.277 105.112 365.369
202009 -346.958 106.198 -400.514
202012 -1,259.621 105.765 -1,459.995
202103 439.148 107.357 501.458
202106 858.027 107.579 977.755
202109 613.714 108.759 691.759
202112 2,033.425 109.676 2,272.846
202203 -315.250 111.848 -345.527
202206 -1,963.140 114.072 -2,109.726
202209 276.530 114.715 295.513
202212 29.514 115.179 31.413
202303 511.687 116.507 538.401
202306 1,286.103 117.182 1,345.456
202309 -983.204 118.964 -1,013.175
202312 404.983 118.837 417.772
202403 -197.100 120.123 -201.148
202406 970.659 120.007 991.549
202409 873.152 120.861 885.642
202412 1,205.119 121.135 1,219.592
202503 246.955 122.590 246.955

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Celltrion  (XKRX:068270) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Celltrion's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=161000.00/1122.88
=143.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Celltrion was 9289.71. The lowest was 135.99. And the median was 400.10.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Celltrion Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Celltrion's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Celltrion Business Description

Industry
Traded in Other Exchanges
N/A
Address
13-6 SongDo-Dong, Yeonsu-gu, Incheon City, KOR, 406-840
Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.

Celltrion Headlines

No Headlines